CIK 0001850270 · <br>Emerging growth company
PROKIDNEY CORP.
Sign in to watch- Ticker
- PROK
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- operating
- EIN
- 981586514
- Phone
- 336-999-7028
- Business address
- 2000 FRONTIS PLAZA BLVD., SUITE 250, WINSTON-SALEM, NC, 27103
- Former names
- Social Capital Suvretta Holdings Corp. III
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,067,773
- in 1 filing
Net −$1,067,773. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-01 | Coulston James Chief Financial Officer | Grant or award · Employee stock option (right to buy) | +275,000 | 275,000 | ||
| 2024-03-01 | Girolamo Todd C Chief Legal Officer | Grant or award · Employee stock option (right to buy) | +300,000 | 300,000 | ||
| 2024-03-01 | Girolamo Todd C Chief Legal Officer | Grant or award · Employee stock option (right to buy) | +234,742 | 234,742 | ||
| 2024-03-01 | Weber Darin J. SVP of Regulatory Development | Grant or award · Employee stock option (right to buy) | +225,000 | 225,000 | ||
| 2024-03-01 | Weber Darin J. SVP of Regulatory Development | Grant or award · Employee stock option (right to buy) | +117,264 | 117,264 | ||
| 2024-02-05 | Girolamo Todd C Chief Legal Officer | Conversion | +81,928 | 81,928 | ||
| 2024-02-05 | Girolamo Todd C Chief Legal Officer | Conversion · Class B Ordinary Shares | −81,928 | 245,785 | ||
| 2024-02-05 | Girolamo Todd C Chief Legal Officer | Conversion · Common Units in ProKidney LP | −81,928 | 245,785 | ||
| 2024-02-05 | Weber Darin J. SVP of Regulatory Development | Conversion | +137,073 | 274,073 | ||
| 2024-02-05 | Weber Darin J. SVP of Regulatory Development | Conversion · Class B Ordinary Shares | −137,073 | 402,283 | ||
| 2024-02-05 | Weber Darin J. SVP of Regulatory Development | Conversion · Common Units in ProKidney LP | −137,073 | 402,283 | ||
| 2024-02-05 | Legorreta Pablo G. Director | Conversion | +748,952 | 748,952 | ||
| 2024-02-05 | Legorreta Pablo G. Director | Other disposition | −748,952 | 0 | ||
| 2024-02-05 | Legorreta Pablo G. Director | Conversion · Class B Ordinary Shares | −748,952 | 88,639,961 | ||
| 2024-02-05 | Legorreta Pablo G. Director | Conversion · Common Units in ProKidney LP | −748,952 | 88,639,961 | ||
| 2023-12-03 | Culleton Bruce Chief Executive Officer | Grant or award · Employee stock option (right to buy) | +2,000,000 | 2,000,000 | ||
| 2023-11-19 | Palihapitiya Chamath Former 10% Owner | Sale | −5,183,367 | $1.31 | $6.8M | 0 |
| 2023-11-19 | Palihapitiya Chamath Former 10% Owner | Sale | −2,073,000 | $1.31 | $2.7M | 0 |
| 2023-11-17 | Palihapitiya Chamath 10% owner | Sale | −258,400 | $1.19 | $308K | 5,183,367 |
| 2023-11-16 | Palihapitiya Chamath 10% owner | Sale | −212,100 | $1.22 | $259K | 5,441,767 |
Page 6 of 12 · 231 trades